New AI tool aims to help doctors Fine-Tune diabetes treatment

NCT ID NCT07063420

Recruiting now Disease control Sponsor: Daniel Chernavvsky, MD Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a decision support system (software) that helps healthcare providers choose the best combination of diabetes drugs for people with type 2 diabetes who use insulin. The study will enroll 18 adults and compare blood sugar control using continuous glucose monitors with and without the software. The goal is to see if the tool improves glycemic outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Decision support system software
What this could lead to: If successful, this could help doctors better manage insulin and other diabetes medications, leading to improved blood sugar control for patients.
What could go wrong: This is a very small pilot study with only 18 participants, so results may not apply to everyone. The software is still experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES TREATED WITH INSULIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Locations

University of Virginia Center for Diabetes Technology
RECRUITING

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.